Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors

Yoon Jung Jang & Hye Jin Kang · 2024-11-12

1Citations
TL;DR

The incidence of t-MNs after PARPi therapy in the current study was higher than that of overall t-MNs, which is consistent with the results of previous studies on t-MNs after PARPi therapy.

AI-generated by Semantic Scholar